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Puberty can be a critical period for the long-term development of diseases, especially for stress-related disorders that depend 
on neuroendocrine and immune responses. Some organs like the prostate are prone to diseases that result from neuroendocrine 
or immune challenges, such as cancer. Aim: In the present study, we assessed the long-term effects of an acute pubertal stressor 
(immune-challenge) on the development of precancerous lesions in adult rats, and compared them with testosterone-induced pros-
tatic lesions. Materials and Methods: Pubertal male rats received a single injection of lipopolysaccharide (LPS) or saline during 
puberty (5 weeks old). At adulthood (8 weeks old) males were subcutaneously implanted with either an empty capsule or filled with 
testosterone propionate (100 mg/kg). This resulted in a total of five groups: 1) intact untreated, 2) saline-treated and implanted with 
a blank capsule, 3) saline-treated and implanted with a testosterone capsule, 4) LPS-treated and implanted with a blank capsule, 
5) LPS-treated and implanted with a testosterone capsule. Four weeks later, the rats were sacrified and their prostates processed 
for histology (hematoxylin and eosin stain) and blood serum processed for hormone analysis (testosterone and corticosterone). 
Results: Males treated with LPS (stressed during puberty via immune challenge) expressed epithelium dysplasia (specially in the 
ventral prostate), anisocytosis, presence of mononuclear cells, anisokariosis, non-basal polarity, abnormal nucleus-cytoplasm 
ratio, proplastic myoepithelium, and granular content in the lumen. These histological alterations were similar, but less severe than 
those observed in males implanted with testosterone during adulthood. Conclusion: These results indicate that pubertal exposure 
to an immune challenge (stress) facilitates the long-term development of prostatic lesions in adult male rats.
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The prostate is an exocrine reproductive gland prone 
to different types of diseases such as inflammation 
(prostatitis), progressive enlargement (benign prostatic 
hyperplasia, BPH), and prostate cancer (CaP). The risk 
of CaP involves many environmental and hereditary fac-
tors such as unhealthy diet, obesity, older age, African 
ancestry and atypical sexual hormonal milieu [1–6]. Pre-
cancerous lesions (e.g. epithelium dysplasia, anisocy-
tosis, anisokaryosis, apolarity, etc.) have been reported 
in individuals with a previous history of prostatic chronic 
inflammation due to infections [7], and in experimental 
animals that undergo constant copulation [8], or in those 
treated with systemic testosterone [9, 10] or prolactin [6, 
11]. Accordingly, the risk for development of CaP is higher 
when the prostate is exposed to hormonal and immune 
challenges, especially in individuals at susceptible age, 
with genetic predisposition and unhealthy diets.
Some studies indicate that puberty should be con-
sidered a critical period for the long-term develop-
ment of diseases, especially for those that depend 
on neuroendocrine and immune responses, perhaps 
because during puberty the hypothalamic-pituitary-
adrenal (HPA) axis is more responsive to stressors than 
in adulthood [12]. For instance, as compared to adults, 
pubertal male rats exposed to acute restraint stress 
(30 min) express longer peaks of adrenocorticotropic 
hormone (ACTH) and corticosterone. In addition, after 
chronic restraint stress (30 min daily) pubertal rats 
express higher peaks that return faster to baseline 
levels [13]. Similarly, the serum levels of testoste-
rone [14] and prolactin [15] increase more in pubertal 
rats than in adults after chronic stress. Higher or longer 
hormonal responses during pubertal stress may result 
in enduring changes in hormone-sensitive organs, in-
creasing the susceptibility to severe diseases like CaP.
Some studies in laboratory mice have used the 
bacterial endotoxin lipopolysaccharide (LPS) to in-
duce a stress-like and immune response that induces 
the display of sickness symptoms for about two days 
or less [16–18]. LPS is a component of the cellular 
membrane of gram-negative bacteria. Treatment with 
LPS results in the production of cytokines, cyclooxy-
genase 2 (COX-2), and prostaglandins (PGE2) among 
other molecules [18] which can activate the HPA axis. 
In mice, treatment with LPS at 6 weeks of age (puberty) 
results in permanent neuroendocrine alterations. For 
example, pubertal females that receive LPS display 
reduced sexual receptivity in adulthood. This does not 
occur if LPS is injected during the postnatal weeks 3, 
7, 8 or 10 [19], indicating that the long-term effects 
of LPS treatment occur exclusively when it is expe-
rienced during the pubertal stress sensitive period 
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(5–6 weeks old). Moreover, mice treated with LPS 
at 6 weeks of age display altered behavioral respon-
siveness to estradiol for anxiety-like and depression-
like behaviors and cognitive functioning. These find-
ings suggest that pubertal treatment globally alters the 
behavioral responsiveness to estradiol (and probably 
to other hormones) by affecting both reproductive and 
non-reproductive behaviors [20–22].
Thus, in the present study, we tested the effects 
of pubertal stress on precancerous prostatic lesions 
and levels of hormones known to modulate prostate 
histology and stress. Our first hypothesis stated that 
pubertal treatment with LPS would induce histological 
prostatic lesions in adulthood comparable to the lesions 
observed in males exposed to exogenous systemic tes-
tosterone (a positive control for precancerous lesions). 
In addition, we hypothesized that the baseline blood le-
vels of testosterone and corticosterone would be higher 
in adult males that received LPS during puberty.
MATERIALS AND METhODS
Animals. Forty Wistar male rats (Rattus norvegi-
cus albinus) were purchased and shipped at 4 weeks 
of age from a certified laboratory animal supplier 
in Mexico (Circulo ADN®). They were housed in groups 
of five rats in large Plexiglas cages (50 × 30 × 20 cm) 
and kept in a colony room at the Centro de Investiga-
ciones Cerebrales, Universidad Veracruzana, Mexico, 
in a 12–12 h reverse Light-Dark cycle (lights off 
at 8:00 h). Water and commercial rat chow (RismartÒ) 
were provided ad libitum. All the experimental pro-
cedures were carried out according to the Official 
Mexican Norm for use and care of laboratory animals 
(NOM-062-ZOO-1999) [23] and the International 
Guiding Principles for Biomedical Research [24].
Groups and treatments. The rats were randomly 
assigned to one of the following five groups: 1) intact 
(n = 8), 2) saline-blank (n = 8), 3) saline-testosterone 
(n = 8), 4) LPS-blank (n = 8), 5) LPS-testosterone (n = 8). 
Table 1 indicates treatment for each group and the age 
(weeks) at the time of treatment. At 5 weeks of age, 
rats from groups 4 and 5 received one intraperitoneal 
(i.p.) injection of LPS (LPS from E. coli, Sigma-Aldrich) 
at a dose of 1.5 mg/kg in a volume of 1 ml/kg of sterile 
saline. Groups 2 and 3 received exclusively a saline 
injection (i.p.) and group 1 received no treatment. 
Rats were monitored at 2, 4, 8, 24 and 48 h following 
the injection to detect the presence of five sickness 
symptoms (ptosis, piloerection, lethar gy, huddling) 
as previously reported [18], and the posture of kyphosis. 
Such period is sufficient to detect whether or not rats 
respond to LPS. At each time-point, rats were given 
a score from 0 to 5, depending on the number of symp-
toms observed (Fig. 1). During the following three 
weeks, the rats were handled daily, and their gene ral 
health was monitored. At 8 weeks of age, groups 3 and 
5 were implanted subcutaneously (s.c.) with a silastic 
tube filled with testosterone (Sigma-Aldrich Mexico 
catalogue 1649007), whereas groups 2 and 4 were 
implanted with a blank (empty) capsule. Group 1 re-
ceived no treatment. The silastic tube (Dow Corning 
CorpÒ 25 mm length, 1.57 mm I.D. × 3.18 mm O.D.) 
contained powdered testosterone propionate (Sigma-
Aldrich química, Mexico). This resulted in approximately 
100 mg/kg of body weight as previously used in other 
studies [8, 11, 25]. Surgical implantation of the tube 
was done under inhaled galothane anesthesia, and 
took less than 3 min for each rat. A detailed description 
of the procedure can be found in our previously pub-
lished paper [8]. After confirmation of deep anesthesia, 
we performed a 10 mm skin incision on the lower back. 
A surgical probe was used to separate the skin from the 
muscle. The silastic tube was inserted under the skin 
and pushed rostrally until placed s.c. in the upper back, 
between the two scapulae. The lower back incision was 
sutured and the rat was allowed to fully recover before 
it was placed back into its home cage. Early studies 
showed that these silastic capsules release testoste-
rone at a rate of ~30 µg/day/cm [26].
Table 1. Groups and treatments
Group
Treatment
5 weeks
single intrape-
ritoneal (i.p.)  
injection
8 weeks  
subcutane-
ous (s.c.)  
implant
12 weeks
(1) Intact nothing nothing histopathology
(2) Saline-blank saline empty histopathology
(3) Saline-testosterone saline testosterone histopathology
(4) LPS-blank LPS empty histopathology
(5) LPS-testosterone LPS testosterone histopathology
Note: At 5 weeks of age (puberty) male rats received an i.p. injection of either 
LPS (1.5 mg/kg/ml), saline (1 ml/kg) or nothing. At 8 weeks of age (adult-
hood) the same rats received a s.c. implant filled with testosterone, empty, 
or remained untreated. At 12 weeks of age all the males were sacrificed and 
their prostates processed for histology.
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Fig. 1. Sickness scores in male rats treated either with saline 
or LPS during puberty (5 week old)
Prostate samples and histology. At 12 weeks 
of age the rats were deeply anesthetized with sodium 
pentobarbital (60 mg/kg i.p.). Then, 3 ml of blood were 
obtained by cardiac puncture for hormone analysis (see 
Hormone measurements for further details). After blood 
sampling rats were sacrificed with an overdose of sodium 
pentobarbital (120 mg/kg i.p.). An abdominal incision 
was performed and the accessory sexual organs were 
carefully removed and placed into a container with 0.9% 
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saline solution. The prostate was identified under a dis-
secting microscope (MEJI, EMZ-TRÒ) and divided into 
ventral (VP) and dorsolateral (DLP) prostate. As in our 
previous studies [8, 11] the VP and DLP were soaked 
in 10% formalin for 24 h, then dehydrated in 70% and 
80% alcohol (1 h each), and 95% (3x2 h each), and 100% 
ethanol overnight, plus two more changes (1 h each), 
the following day. Then xylene (3x1 h each), always 
in constant shaking. Tissue was embedded in paraffin 
wax (2x2 h each), sliced (5 µm thick) with a microtome 
(RM 2125RT Leica, Germany), mounted on slides 
in a bath at 52 °C (containing pork skin-based gelatin 
2.5 mg/100 ml) and then processed for hematoxylin 
and eosin (H & E) dye technique as follows: 1 h at 57 °C, 
deparaffinization in xylene (3x5 min each), rehydrated 
in alcohol/xylene (1:1) 5 min, ethanol 96% 3 min, he-
matoxylin (10 min), water (30 s), acid alcohol (quick 
immersion), water (10 s), lithium carbonate (30 s), water 
(10 s), eosin (4 quick immersions). Dehydration in etha-
nol 96% (3 min), ethanol 100% (2 min), ethanol/xylene 
1:1 (2 min), and xylene (5 min). Then, the slides were 
coverslipped with Permount (SP15-500 Fisher chemi-
cals), air dried, and observed under a light microscope 
(Olympus Ax70, Japan). Photomicrographs were taken 
at 40× and analyzed by the same experimenters. As for-
merly reported, we assessed prostate histology by taking 
into consideration 12 histological features (Table 2) [8, 
11]. Experimenters were blind to the treatment at the 
time of diagnosis.
Hormones measurement. Concentrations of tes-
tosterone and corticosterone in blood serum were mea-
sured at one single time point at 12 weeks of age, at the 
time of prostate extraction. Blood was collected in vacu-
tainer tubes containing no anticoagulant and incubated 
in upright position at room temperature for 30 min to allow 
clotting. Tubes were centrifuged for 15 min at 1000 rpm. 
Supernatant was aspirated at room temperature and se-
rum was kept in 500 ml aliquots and frozen at −20 °C for 
a few days until processing. Hormones levels were quan-
tified using enzyme-linked immunosorbent assay (ELISA) 
and commercial kits for testosterone (ALPCO, USA) and 
corticosterone (ALPCO, USA). The procedure was car-
ried out as instructed by the supplier. The assays were 
read in an IMARK microplate reader with the software 
microplate manager from Bio-Rad.
Variables and statistical analysis. Sickness 
score: We examined the intensity (0–5) and duration 
(0–48 h) of sickness after treatment with LPS during 
puberty. The number of rats expressing symptoms 
at each time point were recorded. Histology: Twelve 
histological features were analized in each male in adult-
hood (see Table 2). Tables 3 and 4 indicate histological 
results observed in at least 6 out of 8 males for group. 
Hormones: Levels of testosterone and corticosterone 
(ng/ml) in adulthood were analyzed with a one-way 
analysis of variance (ANOVA), followed by a Fisher 
LSD post hoc test to compare individual differences. 
All statistical analyses were performed using GraphPad 
Prism version 6.00 for Mac, GraphPad Software, La Jolla 
California USA, www.graphpad.com and the alpha level 
was set at p < 0.05.
RESULTS
Sickness score during puberty. Of the 16 rats 
that received LPS during puberty, only two failed 
to express any sickness symptom. The most common 
symptom was lethargy (68%), followed by kyphosis 
(50%), ptosis (38%), huddling (38%) and piloerec-
tion (13%). None of the males from the saline group 
expressed symptoms after injection. Fig. 1 depicts 
the sickness score, indicating that a maximum peak 
response occurred 2 h after injection and lasted for 
less than 24 h.
Table 2. Characterization of both normal (expected) and abnormal  
(non-expected) histology in the prostate of adult rats
Histological feature Region Normal(expected cases)
Abnormal
(non-expected 
cases)
Epithelium form DLP
VP
cubic
columnar
metaplasia,  
dysplasia
Epithelium size DLP
VP
even anisocytosis
Epithelium papillae DLP
VP
scarce plenty
Interstice space DLP
VP
even compressed
Interstice content DLP
VP
collagen mononuclear
Nucleus size DLP
VP
even anisokariosis
Nucleus location DLP
VP
basal cell polarity non-polar
Nucleus-cytoplasm ratio DLP
VP
1:3 < 1:3
Myoepithelium DLP
VP
euplasia proplasia
Pattern (at 4×) DLP
VP
tubular cribiform
Lumen content DLP
VP
amorphous granular
Chromatin DLP
VP
heterochromatin euchromatin
Note: Normal features were inferred from the number of cases observed 
in groups 1 (intact) and 2 (saline-blank) of the present study.
Table 3. Histological features of the VP of males from the different groups. 
Features were accepted when it was observed in at least 6 out of 8 males
Histology
Ventral prostate
Intact Salineblank
Saline
testoste-
rone
LPS
blank
LPS
testoste-
rone
Epithelium
Form columnar columnar dysplasia dysplasia dysplasia
Size anisocy-
tosis
even anisocy-
tosis
anisocy-
tosis
anisocy-
tosis
Papillae plenty plenty plenty plenty plenty
Interstice
Space even even even even even
Content collagen collagen collagen collagen3 collagen
Nucleus
Size even1 even1 anisoka-
ryosis
anisokary-
osis
anisoka-
ryosis
Location polar polar no polar polar no polar
Nucleus:  
cytoplasm
> 1:3 > 1:3 1:1 1:1 1:1
Myoepithelim euplasia euplasia proplasia euplasia proplasia
Pattern (4×) tubular tubular tubular tubular tubular
Lumen  
content
amor-
phous
amorphous amorphous amour-
phous
amorphous
Chromatin hetero-
chrom2
hetero-
chrom2
hetero-
chrom2
hetero-
chrom2
hetero-
chrom2
Notes: 1some cases may express anisokaryosis; 2some cases may express 
euchromatin; 3some cases may express mononuclear content.
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Prostate histology in adulthood. The results 
indicate that pubertal LPS treatment resulted in abnor-
mal prostatic histology in adulthood (see Tables 3, 4, 
Fig. 2–4). For instance, there were more cases of epi-
thelium dysplasia, specially in the VP (see Fig. 2, 3), 
but also anisocytosis, presence of mononuclear cells, 
anisokariosis, non-basal polarity, abnormal nucleus-
cytoplasm ratio, proplastic myoepithelium, and granular 
content in the lumen. These histological features are 
abnormal and can be considered precancerous.
0
20
40
60
80
100
1 2 3 4 5
Pe
rc
en
ta
ge
 o
f c
as
es
Groups
dysplasia
metaplasia
normal
Fig. 2. Epithelium features in the DLP of male rats: 1 — in-
tact untreated; 2 — saline-treated and implanted with a blank 
capsule in adulthood; 3 — saline-treated and implanted with 
a testosterone capsule; 4 — LPS-treated and implanted with 
a blank capsule; 5 — LPS-treated and implanted with a testos-
terone capsule. Histology was assessed with H & E stain in order 
to identify precancerous lesions
Serum levels of testosterone and corticoste-
rone. With regard to testosterone, the ANOVA revealed 
significant differences F(4,35) = 3.5 (p < 0.01). The 
posthoc test indicated that serum from LPS-testos-
terone rats contained significantly higher testosterone 
levels (mean = 10.21 ng/ml) than LPS-blank controls 
(mean = 7.3 ng/ml). LPS-blank rats (mean = 7.2 ng/ml) 
contained lower testosterone levels than saline-testos-
terone rats (mean = 11.05 ng/ml). As expected, saline-
testosterone rats (mean = 11.05 ng/ml) contained higher 
testosterone levels than intact rats (mean = 8.5 ng/ml) 
(Fig. 5). With regard to corticosterone, the analysis did 
not to detect significant differences between groups 
F(4,35) = 0.37 (p > 0.05) (Fig. 6).
Table 4. Histological features of the DLP of males from the different groups. 
Features were accepted when it was observed in at least 6 out of 8 males
Histology
Dorsolateral prostate
Intact Salineblank
Saline
testosterone
LPS
blank
LPS
testosterone
Epithelium
Form cubic cubic4 dysplasia cubic6 dysplasia
Size even even5 anisocytosis anisocytosis anisocytosis
Papillae scarce scarce moderate moderate plenty
Interstice
Space even even even even even
Content collagen collagen collagen mononu-
clear
collagen
Nucleus
Size even1 even1 anisokary-
osis
anisokary-
osis
anisokary-
osis
Location polar polar no polar no polar no polar
Nucleus: 
cytoplasm
> 1:3 > 1:3 1:1 1:1 1:1
Myoepithe-
lium
euplasia2 euplasia2 proplasia proplasia proplasia
Pattern (4×) tubular tubular tubular tubular tubular
Lumen  
content
amor-
phous
amor-
phous
amorphous granular granular
Chromatin hetero-
chrom3
hetero-
chrom3
hetero-
chrom3
hetero-
chrom3
hetero-
chrom3
Notes: 1some cases express anisokariosis; 2some cases express proplasia; 
3some cases express euchromatin; 4some cases express metaplasia; 
5some cases express anisocytosis; 6some cases express dysplasia.
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Fig. 3. Epithelium features in the VP of male rats: 1 — intact untreated; 
2 — saline-treated and implanted with a blank capsule in adulthood; 
3 — saline-treated and implanted with a testosterone capsule; 4 — 
LPS-treated and implanted with a blank capsule; 5 — LPS-treated 
and implanted with a testosterone capsule. Histology was assessed 
with H & E stain in order to identify precancerous lesions
Fig. 4. Photomicrographs of the DLP and VP (× 40). Histological 
abnormalities are observed in treatments saline-testosterone, 
LPS-blank and LPS-testosterone. See Table 2 for details
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DISCUSSION
The results of the present study indicate that 
acute LPS treatment to pubertal rats (5 week old) 
results in long-term abnormal histological features 
of the prostate, observable in adulthood (12 weeks 
old). LPS-treated rats expressed more cases of epi-
thelium dysplasia specially in the VP (see Fig. 2, 3), 
anisocytosis in DLP, presence of mononuclear cells 
in DLP and VP, anisokariosis in DLP and VP, non-basal 
polarity in DLP, abnormal nucleus-cytoplasm ratio 
in DLP and VP, proplastic myoepithelium in DLP and 
granular content in the lumen in DLP. Anisocytosis 
(unequal abnormal size of epithelium cells) and ab-
normal nuclear shape (anisokaryosis) can be used 
to identify cancerous cells [27, 28]. Anysokaryosis, 
apolarity and abnormal nucleus-cytoplasm ratio de-
note changes in chromosome organization, and pre-
sumably affect gene expression [29] that may result 
in metaplasia or dysplasia; the latter considered the 
anteroom of CaP. When pubertal LPS was combined 
with testosterone in adulthood (LPS-testosterone 
group) the number of animals with prostatic lesions 
did not increase. Lesions on these animals were similar 
to those observed in the group that received testos-
terone only (saline-testosterone), suggesting that LPS 
during puberty has no additional effect than those 
caused by testosterone in adulthood, or vice versa. 
However, two males of the LPS-testosterone group 
failed to express sickness symptoms after the injec-
tion with LPS during puberty. Those males expressed 
normal (cubic) epithelium in the DLP, but dysplasia and 
stratified epithelium in the VP, respectively. They also 
expressed anisokaryosis and non-basal polarity. This 
might suggest a link between the susceptibility to ex-
press sickness after receiving LPS in pubertal animals 
and the probability to develop precancerous prostate 
lesions. Further research is needed to investigate this 
possible relationship.
LPS and endocrine alterations. Previous 
stu dies indicate that chronic stress (i.e. restraint) 
during puberty results in higher levels of serum 
testosterone [14], which is a hormone that can 
induce cell division and spontaneous mutations 
within the prostate [9, 10], and a confirmed cause 
of epithelium dysplasia [11]. Accordingly, we first 
hypothesized that acute immune stress during pu-
berty (LPS-induced) would result in higher levels 
of testosterone in adulthood, with the correspond-
ing prostatic lesions. However, the levels of serum 
testosterone increased exclusively in males with 
a testosterone implant (as expected), but not 
in animals that received one injection of LPS dur-
ing puberty (LPS-blank) (see Fig. 5). Some reports 
indicate that the density of androgen receptors (AR) 
is modified in CaP or following an infection [30, 31]. 
We speculate about the possibility that LPS may 
alter the AR density, which would contribute to the 
gland’s susceptibility to suffer spontaneous cell 
division or mutations under the effects of normal 
serum testosterone levels. AR gene can mutate 
or be amplified and therefore may respond to lower 
or equal levels of androgens in adulthood [6, 32–34]. 
Further research is needed to understand the long-
term effects of pubertal LPS on the distribution and 
presence of AR in the adult prostate.
Similarly, we hypothesized that corticosterone 
baseline serum levels would be higher in those adult 
males that received LPS during puberty as a con-
sequence of enduring HPA axis activity enhance-
ment. Indeed, other studies have shown that stress 
in adulthood facilitates the progression of different 
types of cancer [35–38]. For example, stressed rats 
(i.e. isolated) that receive a carcinogenic drug such 
as N-methyl-N-nitrosurea (NMU) express higher lev-
els of blood corticosterone and 30% more mammary 
tumors that express more corticosterone receptors 
(CR) as compared to rats that only receive NMU 
without being stressed [35]. Our results, however, 
indicated that males from all the groups expressed 
similar serum levels of corticosterone in adulthood 
(see Fig. 6). Therefore, we consider that further re-
search is needed to explore the effects of LPS on the 
distribution and proportion of CR in the prostate.
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Fig. 5. Mean ± S.E.M of baseline serum levels of testosterone 
in the different groups: 1 — intact untreated; 2 — saline-treated 
and implanted with a blank capsule in adulthood; 3 — saline- 
treated and implanted with a testosterone capsule; 4 — LPS-
treated and implanted with a blank capsule; 5 — LPS-treated 
and implanted with a testosterone capsule. Different letters 
indicate p < 0.05
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Fig. 6. Mean ± S.E.M of baseline serum levels of corticosterone 
in the different groups: 1 — intact untreated; 2 — saline-treated 
and implanted with a blank capsule in adulthood; 3 — saline-
treated and implanted with a testosterone capsule; 4 — LPS-
treated and implanted with a blank capsule; 5 — LPS-treated 
and implanted with a testosterone capsule
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Some reports indicate that treatment with LPS 
to neonatal rats results in immediate increase 
of corticosterone that does not correspond to adult 
response [39]. For example, in one study 5-day-old 
males were treated with LPS (from S. enterica) and 
4 h later their levels of corticosterone were higher 
(20 ng/ml) than controls (17 ng/ml), but the levels 
of testosterone were lower (0.1 ng/ml) than controls 
(0.4 ng/ml). Interestingly, in adulthood, the levels 
of corticosterone were lower (350 ng/ml) than con-
trols (550 ng/ml) following a stress challenge. LPS 
rats also expressed lower levels of testosterone 
(2 ng/ml) than controls (3 ng/ml) [39]. These al-
terations correlated with the presence of abnormal 
testicular epithelium. Accordingly, LPS in neonatal 
rats affects epithelia and can alter the levels of tes-
tosterone and corticosterone in adulthood, but such 
alterations are observed only following a stress 
challenge.
Stress, inflammation and CaP. LPS increases 
the level of some cytokines such as IL-1b, IL-6, 
IL-10, IL-12 [18, 36], and also IFN-γ, TNF-α [18], and 
NF-kB [40] which results in subclinical inflammation. 
Inflammation is very common within the adult human 
prostate [7], and some studies have reported positive 
correlations between prostatitis and higher probability 
of developing CaP [41, 42]. In our study, LPS-treated 
males expressed more mononuclear cells than con-
trol animals seven weeks later (indicating subclinical 
and chronic inflammation). E. coli and Enterococcus 
spp. are the most common microorganisms causing 
prostatitis [43, 44], and mouse models of prostatitis 
following injections of E. coli also express epithelial 
proliferation and reactive hyperplasia, dysplasia and 
oxidative DNA damage [45, 46]. Other organisms 
such as Pseudomonas spp., Proteus mirabilis, Kleb-
siella spp. and Serratia spp. have also been identified 
as a cause of prostatitis, all of them gram negative 
bacteria (LPS-holders).
Differential effects of LPS on DLP and VP. The 
two portions of the rat’s prostate (DLP and VP) 
respond differently to experimental manipulations 
[8, 11]. For instance, multiple trials of copulation 
result in histological alterations in the DLP, and the 
addition of exogenous testosterone results in even 
greater alterations [8]. However, in the VP copulation 
plus exogenous testosterone results in fewer cases 
of dysplasia. The VP expresses different proportion 
of AR and AR-mRNA [47] and such heterogene-
ity may account for the different effects observed 
following exogenous testosterone with repetitive 
copulation [8]. Interestingly, the results of the pres-
ent study showed that LPS resulted in more cases 
of dysplasia in the VP.
CONCLUSIONS
Pubertal immune challenge results in histological 
alterations in the two prostatic portions (DLP, VP) in adult 
rats. These lesions can be considered precancerous, 
but are not cancer per se, and are likely to be reversible. 
In addition, pubertal LPS treatment does not affect se-
rum testosterone or corticosterone levels in adulthood, 
suggesting that the observed histological alterations 
are not a consequence of abnormal hypothalamic-
pituitary-gonadal or HPA axes activity. Further research 
is needed to understand the specific role of pubertal 
LPS treatment on the levels of AR in the prostate and the 
development and maintenance of prostatic diseases, 
including cancer [48, 49]. We conclude that pubertal 
stress can influence the development of prostatic pre-
cancerous lesions in adulthood.
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